CTSNet Healthcare Disparities in Lung Cancer.mp4 (20.31 MB)

Healthcare Disparities in Lung Cancer

Download (20.31 MB)
posted on 2021-10-15, 15:21 authored by Azante Griffith, Aaron Delman, Robert Van Haren

In the United States, lung cancer is the second most common cancer and the leading cause of cancer mortality. Among those diagnosed, African American and Black men have both the highest incidence rate and the highest age-adjusted mortality rate. Additionally, although this population has comparable rates of tobacco use to other demographics, they still have the highest rates of lung cancer mortality. Lung cancer screening encourages CT imaging on patients age 55 years or older with a 30 year pack history. These 2013 USPSTF guidelines missed many high-risk black smokers due to younger age, fewer pack years and shorter quit times in this population. The recent 2021 update hopes to rectify this disparity by making guidelines more inclusive to ensure that younger patients with lower levels of smoking exposure can be screened. However, there are still other issues with the implementation of lung cancer screening changes, including the inconsistent documentation of patients’ smoking history, the geographic location of screening centers, and the financial burden of screening.

When it comes to lung cancer management, black patients are less likely to be offered and receive surgery, and more likely to receive non-surgical treatment modalities like radiation and chemotherapy. Once black patients do decide to undergo surgery, they are also more likely to have a sub lobar resection rather than a lobectomy. These sub lobar resections, specifically wedge resections, have been associated with a significantly lower probability of survival. Disparities also exist in patient outcomes, with black lung cancer patients experiencing significantly shorter 2-year and 5-year survival rates. In order to mitigate these disparities, healthcare systems must embrace community-engaged approaches and provider-based interventions. As the existence of disparities in lung cancer continue to increase with time, there is a pertinent need for new investigations that attempt to mitigate these disparities in care at the intersection of race, socioeconomic status and lung cancer.


Best AL, Vamos C, Choi SK, Thompson EL, Daley E, Friedman DB. Increasing Routine Cancer Screening Among Underserved Populations Through Effective Communication Strategies: Application of a Health Literacy Framework. J Cancer Educ. 2017 Jun;32(2):213-217. doi: 10.1007/s13187-017-1194-7. Erratum in: J Cancer Educ. 2017 Jun;32(2):218. PMID: 28275965; PMCID: PMC6235169.

Castro S, Sosa E, Lozano V, Akhtar A, Love K, Duffels J, Raz DJ, Kim JY, Sun V, Erhunmwunsee L. The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening. J Thorac Dis. 2021 Jun;13(6):3745-3757. doi: 10.21037/jtd-20-3281. PMID: 34277066; PMCID: PMC8264678.

Colson YL, Shepard JO, Lennes IT. New USPSTF Guidelines for Lung Cancer Screening: Better but Not Enough. JAMA Surg. 2021 Jun 1;156(6):513-514. doi: 10.1001/jamasurg.2021.0242. PMID: 33687427.

Cykert S, Eng E, Manning MA, Robertson LB, Heron DE, Jones NS, Schaal JC, Lightfoot A, Zhou H, Yongue C, Gizlice Z. A Multi-faceted Intervention Aimed at Black-White Disparities in the Treatment of Early Stage Cancers: The ACCURE Pragmatic Quality Improvement trial. J Natl Med Assoc. 2020 Oct;112(5):468-477. doi: 10.1016/j.jnma.2019.03.001. Epub 2019 Mar 28. PMID: 30928088.

Evans N 3rd, Grenda T, Alvarez NH, Okusanya OT. Narrative review of socioeconomic and racial disparities in the treatment of early stage lung cancer. J Thorac Dis. 2021 Jun;13(6):3758-3763. doi: 10.21037/jtd-20-3181. PMID: 34277067; PMCID: PMC8264710.

Farjah F, Wood DE, Yanez ND 3rd, Vaughan TL, Symons RG, Krishnadasan B, Flum DR. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009 Jan;144(1):14-8. doi: 10.1001/archsurg.2008.519. PMID: 19153319; PMCID: PMC2688646.

Khorfan R, Kruser TJ, Coughlin JM, Bharat A, Bilimoria KY, Odell DD. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer. Ann Thorac Surg. 2020 Jul;110(1):228-234. doi: 10.1016/j.athoracsur.2020.01.073. Epub 2020 Mar 5. PMID: 32147416; PMCID: PMC7405040.

Lin Y, Mak KS. Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative review. J Thorac Dis. 2021 Jun;13(6):3764-3771. doi: 10.21037/jtd-20-3199. PMID: 34277068; PMCID: PMC8264671.

Lung Cancer: Screening. Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening. Published March 9, 2021. Accessed July 20, 2021.

Mehta RS, Lenzner D, Argiris A. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study. Ann Surg Oncol. 2012 Mar;19(3):722-7. doi: 10.1245/s10434-011-2087-3. Epub 2011 Sep 27. PMID: 21947698.

Speicher PJ, Gu L, Gulack BC, Wang X, D'Amico TA, Hartwig MG, Berry MF. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. Clin Lung Cancer. 2016 Jan;17(1):47-55. doi: 10.1016/j.cllc.2015.07.005. Epub 2015 Aug 3. PMID: 26602547; PMCID: PMC5040950.

Stein JN, Rivera MP, Weiner A, Duma N, Henderson L, Mody G, Charlot M. Sociodemographic disparities in the management of advanced lung cancer: a narrative review. J Thorac Dis. 2021 Jun;13(6):3772-3800. doi: 10.21037/jtd-20-3450. PMID: 34277069; PMCID: PMC8264681.

U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999-2018): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www.cdc.gov/cancer/dataviz, released in June 2021.

Wolf A, Alpert N, Tran BV, Liu B, Flores R, Taioli E. Persistence of racial disparities in early-stage lung cancer treatment. J Thorac Cardiovasc Surg. 2019 Apr;157(4):1670-1679.e4. doi: 10.1016/j.jtcvs.2018.11.108. Epub 2018 Dec 11. PMID: 30685165; PMCID: PMC6433143.

Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Pérez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021 Jan;124(2):315-332. doi: 10.1038/s41416-020-01038-6. Epub 2020 Sep 9. PMID: 32901135; PMCID: PMC7852513.


Usage metrics




    Ref. manager